Developer docs
API playgroundTry for free, no card

Search company profiles

Randox Toxicology

Full company profile

uuid000ddky

Namestring
Randox Toxicology
Legal namestring
Randox Toxicology Ltd.
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Randox Toxicology Ltd. is a private Northern Ireland-headquartered diagnostics company and associate of Randox Laboratories, specialising in multiplex immunoassay solutions for forensic, post-mortem, clinical, and workplace toxicology. The company develops, manufactures, and globally distributes the patented Biochip Array Technology platform, which enables simultaneous detection of up to 48 analytes from a single sample using competitive chemiluminescent immunoassays read by digital imaging, supported by what the company describes as the world's largest toxicology test menu covering 600+ drugs and drug metabolites.

The product portfolio is anchored by the Evidence Series analyser family — the semi-automated Evidence Investigator, the fully automated benchtop Evidence MultiSTAT, and the next-generation random-access Evidence RABTA — complemented by ToxPlex 29-analyte panels, dedicated drugs-of-abuse (DoA) and new psychoactive substance (NPS) arrays, therapeutic drug monitoring biochips, ELISA kits, and supporting instrumentation. First-to-market assays for emerging threats such as xylazine (2023), nitazenes (2025), and organophosphates (2025) demonstrate a continuous R&D cadence, with content breadth cited as a key competitive differentiator versus single-analyte alternatives.

Commercially, Randox Toxicology operates a direct enterprise sales motion targeting coroners' offices, forensic and hospital laboratories, reference labs, government agencies, and academic institutions across at least 14 countries, supplemented by distributor channels, grant-funded acquisition programmes in the USA and Canada tied to opioid settlement funds, and multilingual digital marketing. Revenue is generated through one-time analyser equipment sales and a recurring consumables stream from proprietary biochips, ELISA kits, and quality control materials, with quote-based multi-year enterprise contracts and no public pricing. The company employs 51-100 staff and benefits from the broader R&D, manufacturing, and distribution infrastructure of its parent, Randox Laboratories.

Short descriptiontext

Randox Toxicology Ltd. is a private Northern Ireland-headquartered diagnostics company that develops, manufactures, and globally distributes the patented Biochip Array Technology platform and Evidence Series analysers for multiplex forensic, post-mortem, clinical, and workplace toxicology testing, serving government forensic labs, medical examiner offices, hospitals, and academic institutions across more than 14 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCrumlin, United Kingdom
HQ citystring
Crumlin
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
forensic toxicology analysers, Biochip Array Technology, drug screening reagents, ELISA test kits, post-mortem toxicology
Industry1 code
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Laboratory Analytical Instruments3826
Product category
Toxicology Diagnostic Instruments
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Analyser Equipment Sales and Leasing
TypeOne Time License
Description

Sale and potentially leasing of Evidence Series analysers including Evidence Investigator, Evidence MultiSTAT, and Evidence RABTA to laboratories and forensic facilities.

randoxtoxicology.com
2Biochip Test Kits and Reagents
TypeUsage Based
Description

Consumable revenue from proprietary biochip arrays and reagents for drug detection across 600+ analytes. Includes DoA arrays, NPS arrays, ToxPlex panels, and TDM assays.

randoxtoxicology.com
3ELISA Test Kits
TypeUsage Based
Description

Sale of ELISA kits for drugs of abuse detection in various biological specimens with excellent correlation to confirmatory methods.

randoxtoxicology.com
4Quality Control Materials
TypeUsage Based
Description

Dedicated multi-analyte reagents and quality control material providing reliable and controlled testing for laboratory compliance.

randoxtoxicology.com
5Grant-Funded Equipment Programs
TypeHardware Sales
Description

Evidence MultiSTAT analyser sales facilitated through government opioid settlement grants in USA and Canada for harm reduction and drug surveillance initiatives.

randoxtoxicology.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise/Custom Pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing not publicly disclosed. Contact sales required for analyser and reagent pricing.

randoxtoxicology.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1Biochip Array Technology
Description

Patented multiplex immunoassay testing platform enabling simultaneous multi-analyte detection from a single sample

randoxtoxicology.com
+6 more records
Core offering1 text field

Randox Toxicology manufactures and sells proprietary Biochip Array Technology-based analytical instruments (Evidence Investigator, Evidence MultiSTAT, Evidence RABTA) and a suite of consumable test kits covering more than 600 drug and metabolite assays for forensic, post-mortem, clinical, and workplace drug screening. The company supplies ELISA kits, biochip test arrays, and the 800TS plate reader to laboratories worldwide, enabling multiplex screening across multiple sample matrices.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Turnaround time reduced from 6-8 weeks to under 30 minutes for post-mortem toxicology
+5 more records
Product overview1 text field

Randox Toxicology delivers a platform-plus-products portfolio built around its proprietary Biochip Array Technology, a patented multiplex immunoassay testing platform that enables simultaneous multi-analyte detection from a single sample. The core analyser family, called the Evidence Series, includes three distinct instruments: the Evidence Investigator (semi-automated benchtop), the Evidence MultiSTAT (fully automated benchtop), and the Evidence RABTA (next-generation random-access analyser). These platforms are complemented by a comprehensive test menu exceeding 600 drugs and drug metabolites across multiple product lines including DoA Arrays (Drugs of Abuse I+, Ultra, Hair), NPS Arrays (New Psychoactive Substances), ToxPlex Array (29-analyte panel), TDM Arrays (Therapeutic Drug Monitoring), and specialized arrays for Nitazenes, Organophosphates, and Xylazine. The company also offers standalone ELISA kits and the 800TS plate reader for laboratories preferring traditional immunoassay workflows.

Product and service1 record
1Evidence Investigator
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers5 records
TypeBroad incumbent
2SCIEX
TypeDirect peer
Description

Danaher-owned specialist in mass spectrometry for forensic, clinical, and research toxicology; competes head-to-head with Randox's Evidence Series in drug screening workflows, particularly for confirmatory testing and high-throughput reference labs.

3Shimadzu Corporation
TypeDirect peer
Description

Major analytical instrument manufacturer with strong mass spectrometry and chromatography footprint in forensic toxicology; offers competing high-throughput screening and confirmation solutions used by police and forensic laboratories globally.

TypeBroad incumbent
Description

Global leader in analytical instruments and IVD reagents with significant presence in forensic and clinical toxicology through its mass spectrometry and immunoassay portfolios; competes with Randox across both hardware and consumables in toxicology labs worldwide.

TypeBroad incumbent
Description

Leading analytical instrument and consumables provider with deep forensic toxicology presence through mass spec, GC, and LC systems; competes with Randox in reference and government forensic lab procurement.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers16 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Randox Toxicology

Toxicology Diagnostic Instrumentsrandoxtoxicology.com

Randox Toxicology Ltd. is a private Northern Ireland-headquartered diagnostics company that develops, manufactures, and globally distributes the patented Biochip Array Technology platform and Evidence Series analysers for multiplex forensic, post-mortem, clinical, and workplace toxicology testing, serving government forensic labs, medical examiner offices, hospitals, and academic institutions across more than 14 countries.

What Randox Toxicology does

Randox Toxicology Ltd. is a private Northern Ireland-headquartered diagnostics company and associate of Randox Laboratories, specialising in multiplex immunoassay solutions for forensic, post-mortem, clinical, and workplace toxicology. The company develops, manufactures, and globally distributes the patented Biochip Array Technology platform, which enables simultaneous detection of up to 48 analytes from a single sample using competitive chemiluminescent immunoassays read by digital imaging, supported by what the company describes as the world's largest toxicology test menu covering 600+ drugs and drug metabolites.

The product portfolio is anchored by the Evidence Series analyser family — the semi-automated Evidence Investigator, the fully automated benchtop Evidence MultiSTAT, and the next-generation random-access Evidence RABTA — complemented by ToxPlex 29-analyte panels, dedicated drugs-of-abuse (DoA) and new psychoactive substance (NPS) arrays, therapeutic drug monitoring biochips, ELISA kits, and supporting instrumentation. First-to-market assays for emerging threats such as xylazine (2023), nitazenes (2025), and organophosphates (2025) demonstrate a continuous R&D cadence, with content breadth cited as a key competitive differentiator versus single-analyte alternatives.

Commercially, Randox Toxicology operates a direct enterprise sales motion targeting coroners' offices, forensic and hospital laboratories, reference labs, government agencies, and academic institutions across at least 14 countries, supplemented by distributor channels, grant-funded acquisition programmes in the USA and Canada tied to opioid settlement funds, and multilingual digital marketing. Revenue is generated through one-time analyser equipment sales and a recurring consumables stream from proprietary biochips, ELISA kits, and quality control materials, with quote-based multi-year enterprise contracts and no public pricing. The company employs 51-100 staff and benefits from the broader R&D, manufacturing, and distribution infrastructure of its parent, Randox Laboratories.

Randox Toxicology firmographics

Firmographics
Name
Randox Toxicology
Legal name
Randox Toxicology Ltd.
Website
https://randoxtoxicology.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Randox Toxicology Ltd. is a private Northern Ireland-headquartered diagnostics company that develops, manufactures, and globally distributes the patented Biochip Array Technology platform and Evidence Series analysers for multiplex forensic, post-mortem, clinical, and workplace toxicology testing, serving government forensic labs, medical examiner offices, hospitals, and academic institutions across more than 14 countries.
Ownership category
akta.pro rank

Randox Toxicology industry classification

Industry
Product category
Toxicology Diagnostic Instruments
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)

Keywords

  • Forensic toxicology analysers
  • Biochip Array Technology
  • Drug screening reagents
  • ELISA test kits
  • Post-mortem toxicology

Where Randox Toxicology is headquartered

Location

Headquarters

HQ city
Crumlin
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Randox Toxicology business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Analyser Equipment Sales and Leasing: Sale and potentially leasing of Evidence Series analysers including Evidence Investigator, Evidence MultiSTAT, and Evidence RABTA to laboratories and forensic facilities.
  2. Biochip Test Kits and Reagents: Consumable revenue from proprietary biochip arrays and reagents for drug detection across 600+ analytes. Includes DoA arrays, NPS arrays, ToxPlex panels, and TDM assays.
  3. ELISA Test Kits: Sale of ELISA kits for drugs of abuse detection in various biological specimens with excellent correlation to confirmatory methods.
  4. Quality Control Materials: Dedicated multi-analyte reagents and quality control material providing reliable and controlled testing for laboratory compliance.
  5. Grant-Funded Equipment Programs: Evidence MultiSTAT analyser sales facilitated through government opioid settlement grants in USA and Canada for harm reduction and drug surveillance initiatives.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise/Custom Pricing

Go-to-market motion3 records

Distribution channels4 records

Marketing channels9 records

Randox Toxicology product offering

Product offering

Core offering

Randox Toxicology manufactures and sells proprietary Biochip Array Technology-based analytical instruments (Evidence Investigator, Evidence MultiSTAT, Evidence RABTA) and a suite of consumable test kits covering more than 600 drug and metabolite assays for forensic, post-mortem, clinical, and workplace drug screening. The company supplies ELISA kits, biochip test arrays, and the 800TS plate reader to laboratories worldwide, enabling multiplex screening across multiple sample matrices.

Product overview

Randox Toxicology delivers a platform-plus-products portfolio built around its proprietary Biochip Array Technology, a patented multiplex immunoassay testing platform that enables simultaneous multi-analyte detection from a single sample. The core analyser family, called the Evidence Series, includes three distinct instruments: the Evidence Investigator (semi-automated benchtop), the Evidence MultiSTAT (fully automated benchtop), and the Evidence RABTA (next-generation random-access analyser). These platforms are complemented by a comprehensive test menu exceeding 600 drugs and drug metabolites across multiple product lines including DoA Arrays (Drugs of Abuse I+, Ultra, Hair), NPS Arrays (New Psychoactive Substances), ToxPlex Array (29-analyte panel), TDM Arrays (Therapeutic Drug Monitoring), and specialized arrays for Nitazenes, Organophosphates, and Xylazine. The company also offers standalone ELISA kits and the 800TS plate reader for laboratories preferring traditional immunoassay workflows.

Differentiator

Problem solved

Functional benefit

Brands

  • Biochip Array Technology: Patented multiplex immunoassay testing platform enabling simultaneous multi-analyte detection from a single sample
  • Evidence Series
  • Evidence MultiSTAT
  • Evidence RABTA
  • Evidence Investigator
  • ToxPlex
  • ELISA Kits

Products and services

  • Evidence Investigator

Quantifiable outcome

  • Turnaround time reduced from 6-8 weeks to under 30 minutes for post-mortem toxicology
  • +5 more outcomes

Companies that use Randox Toxicology

Customer profile

Named customers16 records

Segments6 records

Ideal customer profiles4 records

Randox Toxicology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Randox Toxicology partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Randox Toxicology competitors and assessment

Company assessment

Broad incumbents

  • Waters Corporation:
  • Thermo Fisher Scientific: Global leader in analytical instruments and IVD reagents with significant presence in forensic and clinical toxicology through its mass spectrometry and immunoassay portfolios; competes with Randox across both hardware and consumables in toxicology labs worldwide.
  • Agilent Technologies: Leading analytical instrument and consumables provider with deep forensic toxicology presence through mass spec, GC, and LC systems; competes with Randox in reference and government forensic lab procurement.

Direct peers

  • SCIEX: Danaher-owned specialist in mass spectrometry for forensic, clinical, and research toxicology; competes head-to-head with Randox's Evidence Series in drug screening workflows, particularly for confirmatory testing and high-throughput reference labs.
  • Shimadzu Corporation: Major analytical instrument manufacturer with strong mass spectrometry and chromatography footprint in forensic toxicology; offers competing high-throughput screening and confirmation solutions used by police and forensic laboratories globally.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Randox Toxicology social profiles

Digital presence

Randox Toxicology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Randox Toxicology leadership team

Management profile

Number of profiles

Randox Toxicology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Randox Toxicology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Randox Toxicology

What does Randox Toxicology do?

Randox Toxicology manufactures and sells proprietary Biochip Array Technology-based analytical instruments (Evidence Investigator, Evidence MultiSTAT, Evidence RABTA) and a suite of consumable test kits covering more than 600 drug and metabolite assays for forensic, post-mortem, clinical, and workplace drug screening. The company supplies ELISA kits, biochip test arrays, and the 800TS plate reader to laboratories worldwide, enabling multiplex screening across multiple sample matrices.

Is Randox Toxicology a public or private company?

Randox Toxicology is a private company. It is classified as corporate owned and is currently operating.

When was Randox Toxicology founded?

Randox Toxicology was founded in 2011. It employs 11 to 50 people.

Where is Randox Toxicology based?

Randox Toxicology is headquartered in Crumlin, United Kingdom, in the Europe region.

How does Randox Toxicology make money?

Five revenue lines are on record. Analyser Equipment Sales and Leasing is the primary driver. The others are biochip Test Kits and Reagents, ELISA Test Kits, quality Control Materials and grant-Funded Equipment Programs.

Who are Randox Toxicology's main competitors?

Broad incumbents on record are Waters Corporation, Thermo Fisher Scientific and Agilent Technologies. Direct peers are SCIEX and Shimadzu Corporation.

Does Randox Toxicology have an API?

No public API is recorded for Randox Toxicology.

What industry is Randox Toxicology in?

Randox Toxicology's product category is Toxicology Diagnostic Instruments. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals